Doximity, Inc.
DOCS · NYSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $10,842,383 | $5,022,443 | $6,255,039 | $8,515,882 |
| - Cash | $209,614 | $96,785 | $158,027 | $112,809 |
| + Debt | $12,396 | $14,546 | $15,637 | $1,089 |
| Enterprise Value | $10,645,165 | $4,940,204 | $6,112,649 | $8,404,162 |
| Revenue | $570,399 | $475,422 | $419,052 | $343,548 |
| % Growth | 20% | 13.5% | 22% | – |
| Gross Profit | $514,525 | $424,753 | $365,562 | $303,761 |
| % Margin | 90.2% | 89.3% | 87.2% | 88.4% |
| EBITDA | $240,763 | $182,079 | $135,391 | $118,576 |
| % Margin | 42.2% | 38.3% | 32.3% | 34.5% |
| Net Income | $223,185 | $147,582 | $112,818 | $154,783 |
| % Margin | 39.1% | 31% | 26.9% | 45.1% |
| EPS Diluted | 1.11 | 0.72 | 0.53 | 0.7 |
| % Growth | 54.2% | 35.8% | -24.3% | – |
| Operating Cash Flow | $273,265 | $184,096 | $179,602 | $126,575 |
| Capital Expenditures | -$6,525 | -$5,801 | -$6,184 | -$5,697 |
| Free Cash Flow | $266,740 | $178,295 | $173,418 | $120,878 |